Navigation Links
U.S. Scientists Commit Most Research Fraud: Study
Date:11/16/2010

By Jenifer Goodwin
HealthDay Reporter

TUESDAY, Nov. 16 (HealthDay News) -- A new study finds that nearly 800 research papers were retracted by medical journals for serious errors or faked data over the past decade, many of them authored by U.S. researchers.

In fact, U.S. scientists were responsible for 169 of the papers retracted for seemingly inadvertent yet serious errors, as well as for 84 of the papers retracted for outright fraud, more than any other country.

That doesn't necessarily mean U.S. researchers are more prone to deception, said study author R. Grant Steen, president of Medical Communications Consultants in Chapel Hill, N.C., but could perhaps reflect that U.S.-based researchers publish a larger volume of English-language medical studies than scientists from other nations.

"We need to be careful," Steen said. "Some scientists perceive a paper in a high-impact journal as a doorway to fame and fortune and some are willing to fake data to walk through that doorway."

The study appears in the Nov. 16 online issue of the Journal of Medical Ethics.

Steen searched the PubMed database for every scientific research paper that had been withdrawn from medical journals between 2000 and 2010. Of 788 retractions, he could find a reason for 742 of them, though the reasons given were sometimes vague.

About three-quarters, or 545, were withdrawn because of serious errors. The remainder, or 197, were withdrawn due to data fabrication (manufacturing false data) or falsification (selective editing of data, such as leaving out findings that don't confirm the hoped-for result).

After the United States, China came next with 89 total retractions, including 20 retractions due to fraud. China was followed by Japan, India, the United Kingdom, South Korea and Germany.

Falsified papers were more likely to appear in high-profile, influential medical journals as opposed to more obscure ones.

And some 53 percent of faked research papers had been written by a "repeat offender," that is, an author who had multiple papers withdrawn due to falsehoods. Authors who had papers retracted due to error were less likely than fakers to be repeat offenders, with only about 18 percent having more than one paper withdrawn due to error.

Some of the most notorious cases of fraudulent research cited in the paper included work by Hwang Woo-Suk, a South Korean researcher who, in 2004 and 2005, published two papers in the journal Science in which he reported creating human embryonic stem cells by cloning. Both papers were later retracted after they were found to be largely fabricated.

In another case, Dr. Scott Reuben, an anesthesiologist at Baystate Medical Center in Springfield, Mass., had 13 papers retracted after it was discovered he had fabricated research on postoperative pain medications, particularly the use of celecoxib (Celebrex) and pregabalin (Lyrica).

So why do they do it?

Within academia, researchers can feel pressure to get published in influential journals to secure promotions, get tenure and get more grant money to continue their research, explained David Prentice, a medical ethics expert and senior fellow for life sciences at the Family Research Council.

But not only is lying about data unethical and potentially harmful to patients, it's also self-destructive. When researchers publish a finding, it becomes part of the public record, and other researchers will try to replicate the finding, especially if the original study made a splash.

"As soon as others can't verify what is going on, the doubt comes in," Prentice said. "Inevitably, they are going to be discovered. The short-term success they achieve is ultimately going to lead to long-term failure."

Faked research papers were significantly more likely to have multiple authors, perhaps because it's easier to disguise fraud when each author is aware of only small parts of the research, or because the blame can be more easily spread, Steen said.

More information

The U.S. National Institutes of Health has more on medical ethics.

SOURCES: R. Grant Steen, Ph.D., president, Medical Communications Consultants, Chapel Hill, N.C.; David Prentice, senior fellow, life sciences, Family Research Council, Washington, D.C.; Nov. 16, 2010, Journal of Medical Ethics


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
5. Scientists find donut-shaped structure of enzyme involved in energy metabolism
6. Neuroscientists reveal new links that regulate brain electrical activity
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. Scientists Spot Genetic Fingerprints of Individual Cancers
10. Scientists Unravel Mysteries of Intelligence
11. MSU scientists develop more effective method of predicting lead-poisoning risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Scientists Commit Most Research Fraud: Study
(Date:4/29/2016)... Pass, OR (PRWEB) , ... April 29, 2016 , ... ... suggest dinner as the meal to miss. That was among the many new lifestyle ... Nutrition, on a recent Sharon Kleyne Hour® Power of Water® radio show. Bonny and ...
(Date:4/29/2016)... ... , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) -- Dr. Mickey ... -- are proud of the recent release of their 2014 in vitro fertilization success ... published the latest verified data for 375 U.S. member clinics. *Preliminary data shows HRC/OC ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in ... efficacy of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The ... adding BC and AD, saying it is time to set the record straight. Traditionally, ... says this simply cannot possibly be true and offers explanation. , “To start with, ...
(Date:4/28/2016)... ... April 29, 2016 , ... Sublime Beauty® is offering a special deal on its webstore. ... off. The discount is applied to the product with lesser value. In addition, a ... purchase $250 or more in products. , "So many women (men, too) love our products ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Oasmia Pharmaceutical ... of a new generation of drugs within human ... results for Paclical/Apealea in the Phase III study ... epithelial ovarian cancer. These preliminary results showed non-inferiority ... with carboplatin versus Taxol in combination with carboplatin. ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... 2016 US demand for infection prevention ... percent annually to $27.6 billion in 2020.  Increasing ... decrease rates of healthcare-associated infections (HAIs) will boost ... services.  Although declining, the overall rate of certain ... set by the CDC.  Recent statistics indicate that ...
Breaking Medicine Technology: